Insider · CIK 0001423327

PALEKAR ROHAN

Reports to the SEC for 4 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001423327

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-20	NGNENeurogene Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+12.1K sh	—	—	12,050
2025-10-30	ETNB89bio, Inc.A Award	Director, Chief Executive Officer	AAward	+125K sh	—	—	934,273
2025-10-30	ETNB89bio, Inc.U Disposition from Tender	Director, Chief Executive Officer	UDisposition from Tender	−934K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−120K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−132K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−170K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−204K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−220K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−300K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−605K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−848K sh	—	—	0
2025-08-01	ETNB89bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−55.8K sh	$9.16	−$511K	808,070
2025-06-12	NGNENeurogene Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+12.1K sh	—	—	12,050
2025-02-17	ETNB89bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−3,249 sh	$10.57	−$34.3K	862,240
2025-02-09	ETNB89bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−8,946 sh	$11.41	−$102K	864,692
2025-02-01	ETNB89bio, Inc.A Award	Director, Chief Executive Officer	AAward	+212K sh	—	—	683,236
2025-02-01	ETNB89bio, Inc.A Award	Director, Chief Executive Officer	AAward	+200K sh	—	—	883,236
2025-02-01	ETNB89bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−9,598 sh	$9.60	−$92.1K	873,638
2025-02-01	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+848K sh	—	—	848,000
2024-12-06	ETNB89bio, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+5,000 sh	$7.89	+$39.5K	471,236
2024-11-22	ETNB89bio, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10K sh	$8.35	+$83.5K	466,236
2024-08-17	ETNB89bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−4,601 sh	$8.04	−$37K	456,236
2024-06-14	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,700 sh	—	—	7,700
2024-04-01	ETNB89bio, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+25K sh	$1.93	+$48.3K	511,889
2024-04-01	ETNB89bio, Inc.S Sale	Director, Chief Executive Officer	SSale	−52.7K sh	$10.91	−$575K	459,171
2024-04-01	ETNB89bio, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−25K sh	—	—	120,231
2024-02-26	ETNB89bio, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,477 sh	$10.76	−$48.2K	486,889
2024-02-17	ETNB89bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−4,602 sh	$9.74	−$44.8K	491,366
2024-02-09	ETNB89bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−12.7K sh	$8.45	−$107K	480,968
2024-02-05	ETNB89bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−5,068 sh	$9.80	−$49.7K	493,646
2024-02-01	ETNB89bio, Inc.A Award	Director, Chief Executive Officer	AAward	+150K sh	—	—	498,714
2024-02-01	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+605K sh	—	—	605,000
2024-01-16	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.4K sh	—	—	15,400
2024-01-05	ETNB89bio, Inc.A Award	Director, Chief Executive Officer	AAward	+75K sh	—	—	376,225
2024-01-05	ETNB89bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−27.5K sh	$11.53	−$317K	348,714
2023-12-29	ETNB89bio, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+50K sh	$1.93	+$96.5K	351,225
2023-12-29	ETNB89bio, Inc.S Sale	Director, Chief Executive Officer	SSale	−50K sh	$11.20	−$560K	301,225
2023-12-29	ETNB89bio, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−50K sh	—	—	145,231
2023-08-17	ETNB89bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−4,501 sh	$15.46	−$69.6K	300,950
2023-06-30	ETNB89bio, Inc.A Award	Director, Chief Executive Officer	AAward	+33.3K sh	—	—	321,978
2023-06-30	ETNB89bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−16.5K sh	$18.95	−$313K	305,451
2023-06-08	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-06-05	ETNB89bio, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+15K sh	$1.93	+$29K	301,978
2023-06-05	ETNB89bio, Inc.S Sale	Director, Chief Executive Officer	SSale	−15K sh	$20.00	−$300K	286,978
2023-06-05	ETNB89bio, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−15K sh	—	—	195,231
2023-03-31	ETNB89bio, Inc.A Award	Director, Chief Executive Officer	AAward	+33.3K sh	—	—	302,413
2023-03-31	ETNB89bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−15.4K sh	$15.23	−$235K	286,970
2023-03-23	ETNB89bio, Inc.S Sale	Director, Chief Executive Officer	SSale	−15K sh	$16.00	−$240K	269,080
2023-02-17	ETNB89bio, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−6,279 sh	$13.97	−$87.7K	284,072
2023-02-09	ETNB89bio, Inc.A Award	Director, Chief Executive Officer	AAward	+75K sh	—	—	290,351

Recent filings

Accepted (ET)
Feb 244
PALEKAR ROHAN0001628280-26-011325
SEC(opens sec.gov)
Oct 304
PALEKAR ROHAN0001193125-25-259054
SEC(opens sec.gov)
Aug 54
PALEKAR ROHAN0000950170-25-103374
SEC(opens sec.gov)
Jun 134
PALEKAR ROHAN0001404644-25-000066
SEC(opens sec.gov)
Feb 194
PALEKAR ROHAN0000950170-25-023119
SEC(opens sec.gov)
Feb 114
PALEKAR ROHAN0000950170-25-017866
SEC(opens sec.gov)
Feb 44
PALEKAR ROHAN0000950170-25-014088
SEC(opens sec.gov)
Dec 104
PALEKAR ROHAN0000950170-24-134750
SEC(opens sec.gov)

Companies

Address

C/O NEUROGENE INC. 535 W 24TH STREET, 5TH FLOOR

NEW YORK, NY, 10011